Advertisement

Topics

Discuva Company Profile

04:07 EDT 25th March 2019 | BioPortfolio

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The company’s innovative proprietary technologies both identify new small molecule drugs against novel bacterial targets and facilitate their progression through to drug candidates with low clinical resistance, providing real solutions to the threat of global antibiotic resistance. Based in Cambridge, UK, Discuva’s drug pipeline is focused on providing therapeutics for currently untreatable hospital and community-based infections. For further information visit www.discuva.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathogens at Novel Antimicrobials and AMR Diagnostics 2019 Conference

Summit Therapeutics plc  (‘Summit’ or the ’Company’) Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria Gonorrhoeae and ESKAPE Pathog...

Summit Therapeutics shows off potential of Discuva platform at Berlin conference

The presentations are being made at Novel Antimicrobials and AMR Diagnostics 2019, which is being held in Berlin today and tomorrow

Summit Therapeutics showing off potential of Discuva platform at Berlin conference

The presentations are being made at Novel Antimicrobials and AMR Diagnostics 2019, which is being held in Berlin today and tomorrow

Ridinilazole leading the way as Summit Therapeutics pivots to antibiotics

Following the disappointment of its DMD treatment over summer, Summit is leveraging its Discuva platform to develop new antibiotics, which doctors are in desperate need of

Summit Therapeutics to begin Phase 3 studies of ridinilazol this quarter

Summit Therapeutics PLC (NASDAQ:SMMT) (LON:SUMM) CEO Glyn Edwards caught up with Proactive Investors at the BIO CEO & Investor Conference in New York. Edwards says the company expects to begin...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Discuva

Discuva aims to revolutionise the treatment of disease caused by bacterial infection by discovering and developing new antibiotics against highly drug-resistant pathogens. The com...

More Information about "Discuva" on BioPortfolio

We have published hundreds of Discuva news stories on BioPortfolio along with dozens of Discuva Clinical Trials and PubMed Articles about Discuva for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Discuva Companies in our database. You can also find out about relevant Discuva Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record